Related Experiment Video
Updated: Sep 2, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Inhalable Nano-Dimpled Microspheres Containing Budesonide-PLGA for Improved Aerodynamic Performance
Chang-Soo Han1, Ji-Hyun Kang1, Young-Jin Kim1
1College of Pharmacy, Chungbuk National University, Cheongju, 28160, Republic of Korea.
Nanoscale dimples on microspheres (MSs) significantly improve dry powder inhalation efficiency. This surface roughness enhances aerosolization and lung deposition, leading to better drug delivery for inhalation therapies.
Area of Science:
- Pharmaceutical Sciences
- Biomedical Engineering
- Materials Science
Background:
- Dry powder inhalations (DPIs) offer environmental and stability advantages over other inhalation methods.
- Optimizing drug deposition in the deep lung is crucial for therapeutic efficacy in DPIs.
- Surface properties of microparticles can influence aerosolization and aerodynamic performance.
Purpose of the Study:
- To engineer microspheres with nanoscale dimples.
- To investigate the impact of surface roughness on inhalation efficiency.
- To evaluate the aerodynamic performance and lung deposition of dimpled microspheres.
Main Methods:
- Microspheres with dimpled surfaces were fabricated using oil-in-water emulsion-solvent evaporation.
- Physicochemical properties of the microspheres were characterized.
- In vitro aerodynamic performance was assessed using particle image velocimetry and computational fluid dynamics.
Main Results:
- Dimpled microspheres exhibited improved aerosolization characteristics, including reduced axial velocity.
- Computational fluid dynamics confirmed that dimpled surfaces promote deep lung transit.
- Andersen Cascade Impactor tests showed a higher fine particle fraction for dimpled microspheres.
Conclusions:
- Nanoscale surface roughness, specifically dimples, enhances the aerosolization and aerodynamic performance of microspheres.
- Dimpled microspheres demonstrate improved potential for deep lung deposition, increasing inhalation efficiency.
- Surface modification of microparticles is a viable strategy to optimize DPI formulations.
Related Concept Videos
Inhaled Medications
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...

